You are here

Publications

Found 71 results
Author [ Title(Asc)] Type Year
Filters: Author is Ma, Xiaojing  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Du Q, Xie J, Kim H-J, Ma X.  2013.  Type I interferon: the mediator of bacterial infection-induced necroptosis.. Cell Mol Immunol. 10(1):4-6.
Zhang Y, Ma X.  2010.  Triptolide inhibits IL-12/IL-23 expression in APCs via CCAAT/enhancer-binding protein alpha.. J Immunol. 184(7):3866-77.
Kim S, Elkon KB, Ma X.  2004.  Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.. Immunity. 21(5):643-53.
Jayakumar A, Widenmaier R, Ma X, McDowell MAnn.  2008.  Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.. J Parasitol. 94(1):84-93.
Homma Y, Cao S, Shi X, Ma X.  2007.  The Th2 transcription factor c-Maf inhibits IL-12p35 gene expression in activated macrophages by targeting NF-kappaB nuclear translocation.. J Interferon Cytokine Res. 27(9):799-808.
Song M, Wang C, Wang H, Zhang T, Li J, Benezra R, Chouchane L, Sun Y-H, Cui X-G, Ma X.  2020.  Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.. Oncoimmunology. 9(1):1746148.
Ban Y, Mai J, Li X, Mitchell-Flack M, Zhang T, Zhang L, Chouchane L, Ferrari M, Shen H, Ma X.  2017.  Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.. Cancer Res. 77(11):2857-2868.
Rafiq S, Yeku OO, Jackson HJ, Purdon TJ, van Leeuwen DG, Drakes DJ, Song M, Miele MM, Li Z, Wang P et al..  2018.  Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.. Nat Biotechnol. 36(9):847-856.
R
Yamamoto S, Ma X.  2009.  Role of Nod2 in the development of Crohn's disease.. Microbes Infect. 11(12):912-8.
Liu J, Xiang Z, Ma X.  2004.  Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma.. J Immunol. 173(2):1184-93.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.. Infect Immun. 74(7):4370-4.
Murray HW, Xiang Z, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.. Am J Trop Med Hyg. 74(6):1013-5.
Murray HW, Zhang Y, Zhang Y, Raman VS, Reed SG, Ma X.  2013.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.. Infect Immun. 81(7):2318-26.
Mitsuhashi M, Liu J, Cao S, Shi X, Ma X.  2004.  Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.. J Leukoc Biol. 76(2):322-32.
Zhang Y, Kim H-J, Yamamoto S, Kang X, Ma X.  2010.  Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells.. J Interferon Cytokine Res. 30(3):113-22.
Liu J, Guan X, Ma X.  2007.  Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways.. J Exp Med. 204(1):141-52.
Schlitzer A, Zhang W, Song M, Ma X.  2018.  Recent advances in understanding dendritic cell development, classification, and phenotype.. F1000Res. 7